☆ 4.6 Article

Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy

THROMBOSIS RESEARCH (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Florian Moik et al.

Summary: The study found that cancer patients undergoing therapy with immune checkpoint inhibitors were at a high risk of thromboembolism, particularly venous thromboembolism (VTE). The occurrence of VTE was associated with increased mortality. Patients with a history of VTE were more likely to develop VTE, and distant metastasis may be related to VTE risk.

BLOOD (2021)

添加到收藏夹

Article Hematology

Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study

Joanna Roopkumar et al.

Summary: Patients with ALK-mutant advanced lung adenocarcinoma have the highest rate of TE, which is associated with worse survival across all molecular subtypes. These findings underscore the importance of considering thromboprophylaxis in clinical decision-making.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Hematology

Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors

Oded Icht et al.

Summary: VTE rates were higher among NSCLC patients treated with platinum-based chemotherapy compared to those treated with ICI. The Khorana Score did not effectively identify high-risk ICI-treated patients, suggesting the need for an ICI-specific risk model.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Increased incidence of venous thromboembolism with cancer immunotherapy

Joanna Roopkumar et al.

Summary: The study reveals a potential association between cancer immunotherapy and venous thromboembolism, impacting overall survival. Higher levels of interleukin-8 and myeloid-derived suppressor cells may play a role in the pathogenesis of venous thromboembolism in individuals undergoing immunotherapy.

MED (2021)

添加到收藏夹

Article Oncology

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

Nigel S. Key et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Hematology

Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study

Feifei Dou et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Hematology

The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis

Nick van Es et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Medicine, General & Internal

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

A. A. Khorana et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Medicine, General & Internal

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Marc Carrier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab-induced acute thrombosis: A case report

Kei Kunimasa et al.

MEDICINE (2018)

添加到收藏夹

Article Hematology

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

Adam Cuker et al.

BLOOD ADVANCES (2018)

添加到收藏夹

Article Oncology

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data

Alex J. Walker et al.

BRITISH JOURNAL OF CANCER (2016)

添加到收藏夹

Article Hematology

Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer

A. S. Mansfield et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)

添加到收藏夹

Article Hematology

Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism

Ambarina S. Faiz et al.

THROMBOSIS RESEARCH (2015)

添加到收藏夹

Article Oncology

Bevacizumab and the Risk of Arterial and Venous Thromboembolism in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)

Jai N. Patel et al.

CANCER (2015)

添加到收藏夹

Review Hematology

Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment

R. E. J. Roach et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)

添加到收藏夹

Review Oncology

Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trials

F. Petrelli et al.

ANNALS OF ONCOLOGY (2012)

添加到收藏夹

Article Hematology

Cigarette smoking and the risk of venous thromboembolism: The Tromso Study

K. F. Enga et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)

添加到收藏夹

Article Oncology

Venous Thromboembolism (VTE) in Patients with Cancer: Epidemiology and Risk Factors

Ted Wun et al.

CANCER INVESTIGATION (2009)

添加到收藏夹

Article Hematology

Development and validation of a predictive model for chemotherapy-associated thrombosis

Alok A. Khorana et al.

BLOOD (2008)

添加到收藏夹

Article Medicine, General & Internal

Relative impact of risk factors for deep vein thrombosis and pulmonary embolism - A population-based study

JA Heit et al.

ARCHIVES OF INTERNAL MEDICINE (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.